These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10771673)

  • 1. [Development of new specific inhibitors for cathepsins and its application for medical field].
    Katunuma N; Tsuge H; Asao T
    Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1057-64. PubMed ID: 10771673
    [No Abstract]   [Full Text] [Related]  

  • 2. [Structure-based drug development and medical/biological application of cathepsin specific inhibitors].
    Katunuma N
    Seikagaku; 2009 Nov; 81(11):952-61. PubMed ID: 19999577
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of cathepsin activities by vitamin B6 derivatives.
    Matsui A; Tsuzuki H; Murata E; Tada Y; Asao T; Katunuma N
    Biofactors; 2000; 11(1-2):117-20. PubMed ID: 10705980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of selective Cathepsin inhibitors.
    Bethel PA; Gerhardt S; Jones EV; Kenny PW; Karoutchi GI; Morley AD; Oldham K; Rankine N; Augustin M; Krapp S; Simader H; Steinbacher S
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4622-5. PubMed ID: 19616430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 3: heterocyclic P3.
    Tully DC; Liu H; Alper PB; Chatterjee AK; Epple R; Roberts MJ; Williams JA; Nguyen KT; Woodmansee DH; Tumanut C; Li J; Spraggon G; Chang J; Tuntland T; Harris JL; Karanewsky DS
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1975-80. PubMed ID: 16446091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel class of succinyl-nitrile-based Cathepsin S inhibitors.
    Bekkali Y; Thomson DS; Betageri R; Emmanuel MJ; Hao MH; Hickey E; Liu W; Patel U; Ward YD; Young ER; Nelson R; Kukulka A; Brown ML; Crane K; White D; Freeman DM; Labadia ME; Wildeson J; Spero DM
    Bioorg Med Chem Lett; 2007 May; 17(9):2465-9. PubMed ID: 17379516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?
    Adkison KK; Barrett DG; Deaton DN; Gampe RT; Hassell AM; Long ST; McFadyen RB; Miller AB; Miller LR; Payne JA; Shewchuk LM; Wells-Knecht KJ; Willard DH; Wright LL
    Bioorg Med Chem Lett; 2006 Feb; 16(4):978-83. PubMed ID: 16290936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification of potent, selective, and bioavailable cathepsin S inhibitors.
    Gauthier JY; Black WC; Courchesne I; Cromlish W; Desmarais S; Houle R; Lamontagne S; Li CS; Massé F; McKay DJ; Ouellet M; Robichaud J; Truchon JF; Truong VL; Wang Q; Percival MD
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4929-33. PubMed ID: 17590332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Cyano-pyrimidines: a new chemotype for inhibitors of the cysteine protease cathepsin K.
    Altmann E; Aichholz R; Betschart C; Buhl T; Green J; Irie O; Teno N; Lattmann R; Tintelnot-Blomley M; Missbach M
    J Med Chem; 2007 Feb; 50(4):591-4. PubMed ID: 17256925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptide nitrile inhibitors of cathepsin K.
    Altmann E; Aichholz R; Betschart C; Buhl T; Green J; Lattmann R; Missbach M
    Bioorg Med Chem Lett; 2006 May; 16(9):2549-54. PubMed ID: 16480867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of selective, nonpeptidic nitrile inhibitors of cathepsin s using the substrate activity screening method.
    Patterson AW; Wood WJ; Hornsby M; Lesley S; Spraggon G; Ellman JA
    J Med Chem; 2006 Oct; 49(21):6298-307. PubMed ID: 17034136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel purine nitrile derived inhibitors of the cysteine protease cathepsin K.
    Altmann E; Cowan-Jacob SW; Missbach M
    J Med Chem; 2004 Nov; 47(24):5833-6. PubMed ID: 15537340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclic, orally bioavailable ketone-based cathepsin K inhibitors.
    Barrett DG; Catalano JG; Deaton DN; Long ST; McFadyen RB; Miller AB; Miller LR; Samano V; Tavares FX; Wells-Knecht KJ; Wright LL; Zhou HQ
    Bioorg Med Chem Lett; 2007 Jan; 17(1):22-7. PubMed ID: 17157021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of lysosomal cathepsins in naphthazarin- and Fas-induced apoptosis in oral squamous cell carcinoma cells.
    Johansson AC; Norberg-Spaak L; Roberg K
    Acta Otolaryngol; 2006 Jan; 126(1):70-81. PubMed ID: 16308258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in cathepsin K inhibitor design.
    Grabowskal U; Chambers TJ; Shiroo M
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):619-30. PubMed ID: 16159024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring inhibitor binding at the S' subsites of cathepsin L.
    Chowdhury SF; Joseph L; Kumar S; Tulsidas SR; Bhat S; Ziomek E; Ménard R; Sivaraman J; Purisima EO
    J Med Chem; 2008 Mar; 51(5):1361-8. PubMed ID: 18278855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide ketobenzoxazole inhibitors bound to cathepsin K.
    McGrath ME; Sprengeler PA; Hill CM; Martichonok V; Cheung H; Somoza JR; Palmer JT; Janc JW
    Biochemistry; 2003 Dec; 42(51):15018-28. PubMed ID: 14690410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-substituted cyclohexanecarboxamide: a nonpeptidic framework for the design of potent inhibitors of cathepsin K.
    Crane SN; Black WC; Palmer JT; Davis DE; Setti E; Robichaud J; Paquet J; Oballa RM; Bayly CI; McKay DJ; Somoza JR; Chauret N; Seto C; Scheigetz J; Wesolowski G; Massé F; Desmarais S; Ouellet M
    J Med Chem; 2006 Feb; 49(3):1066-79. PubMed ID: 16451072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-Amino-2-cyanopyrimidines: novel scaffold for nonpeptidic cathepsin S inhibitors.
    Irie O; Yokokawa F; Ehara T; Iwasaki A; Iwaki Y; Hitomi Y; Konishi K; Kishida M; Toyao A; Masuya K; Gunji H; Sakaki J; Iwasaki G; Hirao H; Kanazawa T; Tanabe K; Kosaka T; Hart TW; Hallett A
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4642-6. PubMed ID: 18662880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Z-Phe-Gly-NHO-Bz, an inhibitor of cysteine cathepsins, induces apoptosis in human cancer cells.
    Zhu DM; Uckun FM
    Clin Cancer Res; 2000 May; 6(5):2064-9. PubMed ID: 10815933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.